Terms: = Prostate cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L
368 results:
1. Primary mucinous adenocarcinoma of the urethra: A contemporary clinicopathologic analysis of 17 patients.
Alrohaibani A; Osunkoya AO
Pathol Res Pract; 2024 Apr; 256():155273. PubMed ID: 38565023
[TBL] [Abstract] [Full Text] [Related]
2. tp63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer.
Sultanov R; Mulyukina A; Zubkova O; Fedoseeva A; Bogomazova A; Klimina K; Larin A; Zatsepin T; Prikazchikova T; Lukina M; Bogomiakova M; Sharova E; Generozov E; Lagarkova M; Arapidi G
Epigenetics Chromatin; 2024 Mar; 17(1):6. PubMed ID: 38481282
[TBL] [Abstract] [Full Text] [Related]
3. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases.
Ji J; Liu T; Yao Y; Liu W; Ning H; Wang T; Zhang G
Neoplasia; 2024 Jan; 47():100961. PubMed ID: 38142529
[TBL] [Abstract] [Full Text] [Related]
5. Integrative bioinformatics analysis of biomarkers and pathways for exploring the mechanisms and molecular targets associated with pyroptosis in type 2 diabetes mellitus.
Wang W; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1207142. PubMed ID: 38034011
[TBL] [Abstract] [Full Text] [Related]
6. Deep learning approach for accurate prostate cancer identification and stratification using combined immunostaining of cytokeratin, p63, and racemase.
Salvi M; Manini C; López JI; Fenoglio D; Molinari F
Comput Med Imaging Graph; 2023 Oct; 109():102288. PubMed ID: 37633031
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathological Features of Primary Small Cell Neuroendocrine Carcinoma of the Bladder].
Gu YM; Liang XL; Zhang YG; Zhao HY; Jin ML; Li X; Lu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):429-435. PubMed ID: 37407530
[TBL] [Abstract] [Full Text] [Related]
8. A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy.
Lee CT; Koleoso O; Deng M; Veltchev I; Lin T; Hallman MA; Horwitz EM; Wong JK
Brachytherapy; 2023; 22(5):586-592. PubMed ID: 37393186
[TBL] [Abstract] [Full Text] [Related]
9. Grading Intraductal Carcinoma of the prostate; ISUP versus GUPS Recommendations.
Shahid A; Mushtaq S; Maqbool H; Hassan U; Hussain M; Syed M
J Coll Physicians Surg Pak; 2023 Apr; 33(4):396-399. PubMed ID: 37190710
[TBL] [Abstract] [Full Text] [Related]
10. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
Naik M; Rao BV; Challa S; Fonseca D; Sudha SM; Giridhar A; Sharma R; Raju KVVN; Rao TS
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147963
[TBL] [Abstract] [Full Text] [Related]
11. DIAGNOSTIC UTILITY OF IMMUNOHISTOCHEMICAL EXPRESSION OF KI!67, p63 AND AMACR IN prostate INTRAEPITHELIAL NEOPLASIA.
Melnychuk MP
Wiad Lek; 2023; 76(2):420-426. PubMed ID: 37010182
[TBL] [Abstract] [Full Text] [Related]
12. Novel Paired Normal prostate and prostate cancer Model Cell Systems Derived from African American Patients.
Jung M; Kowalczyk K; Hankins R; Bandi G; Kallakury B; Carrasquilla MA; Banerjee PP; Grindrod S; Dritschilo A
Cancer Res Commun; 2022 Dec; 2(12):1617-1625. PubMed ID: 36970725
[TBL] [Abstract] [Full Text] [Related]
13. Sclerosing Adenosis of the prostate-A Benign Lesion Similar to prostate cancer: A Case Report and Literature Review.
Yao H; Tang G; Cui Y; Wu J
Am J Mens Health; 2022; 16(6):15579883221143182. PubMed ID: 36527372
[TBL] [Abstract] [Full Text] [Related]
14. prostate cancer: Update on Grading and Reporting.
Baraban E; Epstein J
Surg Pathol Clin; 2022 Dec; 15(4):579-589. PubMed ID: 36344176
[TBL] [Abstract] [Full Text] [Related]
15. Cytomorphology, immunoprofile, and clinicopathologic correlation of metastatic prostatic carcinoma.
Lin X; Shi Q; Yang XJ
Hum Pathol; 2022 Dec; 130():36-46. PubMed ID: 36244466
[TBL] [Abstract] [Full Text] [Related]
16. Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of prostate.
Thomas T; Wedden S; Afzal N; Mikel J; D'Arrigo C
Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):585-591. PubMed ID: 36083158
[TBL] [Abstract] [Full Text] [Related]
17. Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.
Zhao T; Chuang HW; Cornejo KM; Crotty RK; Dahl DM; Wszolek MF; Zlatev DV; Zietman AL; Wu CL
Hum Pathol; 2022 Oct; 128():101-109. PubMed ID: 35926810
[TBL] [Abstract] [Full Text] [Related]
18. Rapid Histological Assessment of prostate Specimens in the Three-dimensional Space by Hydrophilic Tissue Clearing and Confocal Microscopy.
Peng YC; Lin YC; Hung YL; Fu CC; Chang MD; Lin YY; Chou TY
J Histochem Cytochem; 2022 Aug; 70(8):597-608. PubMed ID: 35912522
[TBL] [Abstract] [Full Text] [Related]
19. Immunomolecular Investigation of Human Papillomavirus Genotypes (16, 18) and p63 Expression in Patients with Malignant and Non-malignant Colorectal Tumors.
Kadhem Mallakh M; Mohammed Mahmood M; Hasan Mohammed Ali S
Arch Razi Inst; 2022 Feb; 77(1):383-390. PubMed ID: 35891769
[TBL] [Abstract] [Full Text] [Related]
20. Expansion of mouse castration-resistant intermediate prostate stem cells in vitro.
Xu Y; Mu J; Zhou Z; Leng Y; Yu Y; Song X; Liu A; Zhu H; Li J; Wang D
Stem Cell Res Ther; 2022 Jul; 13(1):299. PubMed ID: 35841025
[TBL] [Abstract] [Full Text] [Related]
[Next]
